Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes
14 Aug, 2020 | 01:44h | UTC
Commentary on Twitter
Inactivated #COVID19 #vaccine had a low rate of adverse reactions and demonstrated immunogenicity, but longer-term assessment of safety and efficacy will require phase 3 trials https://t.co/atmhXFFHSw
— JAMA (@JAMA_current) August 13, 2020